Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 18281 - 18300 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L04AJ02) ravulizumab (adm: P) | Ultomiris 300 mg/3 mL injection, 3 mL vial | Solution concentrate for I.V. infusion 300 mg in 3 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsAustralasiaPtyLtd |
| Australia | (L04AJ02) ravulizumab (adm: P) | Ultomiris 300 mg/3 mL injection, 3 mL vial | Solution concentrate for I.V. infusion 300 mg in 3 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsAustralasiaPtyLtd |
| Australia | (L04AJ02) ravulizumab (adm: P) | Ultomiris 300 mg/3 mL injection, 3 mL vial | Solution concentrate for I.V. infusion 300 mg in 3 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsAustralasiaPtyLtd |
| Australia | (L04AJ02) ravulizumab (adm: P) | Ultomiris 300 mg/3 mL injection, 3 mL vial | Solution concentrate for I.V. infusion 300 mg in 3 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsAustralasiaPtyLtd |
| Australia | (L04AJ02) ravulizumab (adm: P) | Ultomiris 300 mg/3 mL injection, 3 mL vial | Solution concentrate for I.V. infusion 300 mg in 3 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsAustralasiaPtyLtd |
| Australia | (L04AJ02) ravulizumab (adm: P) | Ultomiris 300 mg/3 mL injection, 3 mL vial | Solution concentrate for I.V. infusion 300 mg in 3 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsAustralasiaPtyLtd |
| Australia | (L04AJ02) ravulizumab (adm: P) | Ultomiris 300 mg/3 mL injection, 3 mL vial | Solution concentrate for I.V. infusion 300 mg in 3 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsAustralasiaPtyLtd |
| Australia | (L04AJ02) ravulizumab (adm: P) | Ultomiris 300 mg/3 mL injection, 3 mL vial | Solution concentrate for I.V. infusion 300 mg in 3 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | AlexionPharmaceuticalsAustralasiaPtyLtd |
| Australia | (L04AJ03) pegcetacoplan (adm: P, previous atc code l04aa54. new atc 4th level l04aj valid from january 2024.) | Empaveli 1.08 g/20 mL injection, 20 mL vial | Solution for subcutaneous infusion 1,080 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | SwedishOrphanBiovitrumPtyLtd |
| Australia | (L04AJ03) pegcetacoplan (adm: P, previous atc code l04aa54. new atc 4th level l04aj valid from january 2024.) | Empaveli 1.08 g/20 mL injection, 20 mL vial | Solution for subcutaneous infusion 1,080 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | SwedishOrphanBiovitrumPtyLtd |
| Australia | (L04AJ03) pegcetacoplan (adm: P, previous atc code l04aa54. new atc 4th level l04aj valid from january 2024.) | Empaveli 1.08 g/20 mL injection, 20 mL vial | Solution for subcutaneous infusion 1,080 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | SwedishOrphanBiovitrumPtyLtd |
| Australia | (L04AJ03) pegcetacoplan (adm: P, previous atc code l04aa54. new atc 4th level l04aj valid from january 2024.) | Empaveli 1.08 g/20 mL injection, 20 mL vial | Solution for subcutaneous infusion 1,080 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Hemoglobinuria, Paroxysmal | SwedishOrphanBiovitrumPtyLtd |
| Australia | (L04AJ06) zilucoplan | Zilbrysq 16.6 mg/0.416 mL injection, 28 x 0.416 mL syringes | Solution for injection 16.6 mg in 0.416 mL (as tetrasodium) pre-filled syringe, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCBAustraliaProprietaryLimited |
| Australia | (L04AJ06) zilucoplan | Zilbrysq 16.6 mg/0.416 mL injection, 28 x 0.416 mL syringes | Solution for injection 16.6 mg in 0.416 mL (as tetrasodium) pre-filled syringe, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCBAustraliaProprietaryLimited |
| Australia | (L04AJ06) zilucoplan | Zilbrysq 23 mg/0.574 mL injection, 28 x 0.574 mL syringes | Solution for injection 23 mg in 0.574 mL (as tetrasodium) pre-filled syringe, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCBAustraliaProprietaryLimited |
| Australia | (L04AJ06) zilucoplan | Zilbrysq 23 mg/0.574 mL injection, 28 x 0.574 mL syringes | Solution for injection 23 mg in 0.574 mL (as tetrasodium) pre-filled syringe, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCBAustraliaProprietaryLimited |
| Australia | (L04AJ06) zilucoplan | Zilbrysq 32.4 mg/0.81 mL injection, 28 x 0.81 mL syringes | Solution for injection 32.4 mg in 0.810 mL (as tetrasodium) pre-filled syringe, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCBAustraliaProprietaryLimited |
| Australia | (L04AJ06) zilucoplan | Zilbrysq 32.4 mg/0.81 mL injection, 28 x 0.81 mL syringes | Solution for injection 32.4 mg in 0.810 mL (as tetrasodium) pre-filled syringe, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCBAustraliaProprietaryLimited |
| Australia | (L04AX02) thalidomide (adm: O) | Thalomid 100 mg capsule, 28 | Capsule 100 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L04AX02) thalidomide (adm: O) | Thalomid 50 mg capsule, 28 | Capsule 50 mg, 28 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbAustraliaPtyLtd |
Pages
